Darbepoetin alfa Completed Phase 4 Trials for Anemia Associated With End Stage Renal Disease (ESRD) Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT02049346Comparison Among Erythropoietin Stimulating Agents